Wednesday, September 4, 2019

Home » » AstraZeneca's Tagrisso gets China OK for type of lung cancer

AstraZeneca's Tagrisso gets China OK for type of lung cancer

No comments
AstraZeneca Plc said on Wednesday it had received marketing authorization from China's National Medical Products Administration for its top-selling drug, Tagrisso, to treat adults with a form of lung cancer.


from Reuters: Health News https://ift.tt/32uSG4i
via IFTTT
Share:  Facebook Twitter Google+

0 comments:

Post a Comment